Stay updated on Anti-CD38 Antibody Trial in CD38+ Malignancies
Sign up to get notified when there's something new on the Anti-CD38 Antibody Trial in CD38+ Malignancies page.

Latest updates to the Anti-CD38 Antibody Trial in CD38+ Malignancies page
- Check4 days agoNo Change Detected
- Check11 days agoNo Change Detected
- Check19 days agoChange DetectedSite version updated from v3.4.3 to v3.5.0.SummaryDifference0.0%

- Check26 days agoChange DetectedPage revision updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check54 days agoChange DetectedAdded Revision: v3.4.2 and removed the funding lapse notice as well as Revision: v3.4.1 from the page.SummaryDifference0.2%

- Check61 days agoChange DetectedSite-wide notice about government funding and NIH Clinical Center status has been added, with links to cc.nih.gov and opm.gov. The page revision tag has been updated from v3.4.0 to v3.4.1.SummaryDifference0.2%

- Check68 days agoChange DetectedShow glossary toggle added; QC-related label updated to 'Last Update Submitted that Met QC Criteria', capitalization adjusted for 'No FEAR Act Data', and the revision tag changed to 'Revision: v3.4.0' (replacing v3.3.4).SummaryDifference0.1%

- Check82 days agoChange DetectedRevision: v3.3.4 is now displayed, replacing the previous Revision: v3.3.3; this change is limited to metadata and does not alter page content or functionality. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to Anti-CD38 Antibody Trial in CD38+ Malignancies
Enter your email address, and we'll notify you when there's something new on the Anti-CD38 Antibody Trial in CD38+ Malignancies page.